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Conclusion: We found considerable variation in bladder dose 
and volumes throughout the treatment course. Inclusion of 
inter-fractional bladder deformations should, therefore, 
likely be considered in future dose-response modeling of GU 
toxicity. 
 
Poster: Physics track: Adaptive radiotherapy for inter-
fraction motion management  
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Purpose or Objective: The MR-Linac (MRL) combines a linear 
accelerator and a 1.5T MRI scanner, which provides the 
possibility for on line adaptation on the current anatomy. In 
the current workflow, compensation for discrepancies 
between pre-treatment and daily treatment geometry is 
performed using couch translations. On the MRL it is not 
possible to shift the couch in left-right and anterior-posterior 
direction. Instead a Virtual Couch Shift (VCS) is applied: the 
pre-treatment dose distribution is shifted to cover the target 
volume by moving the MLC aperture. After VCS, it is also 
possible to perform Segment Weight Optimization (SWO) and 
Segment Shape Optimization (SSO). The first in man on the 
MRL will be a patient with vertebral metastases. The purpose 
of this study was to assess the accuracy and usability of VCS 
and possibly subsequent optimization for palliative treatment 
of patients with vertebral metastases. 
 
Material and Methods: Three patients with repeated CT 
scans of the thoracic spine were included. A CTV of one 
thoracic vertebra was delineated, a PTV was created with an 
isotropic margin of 5 mm around the CTV. A clinical 
reference plan with a prescription dose of 800cGy (single 
fraction) was created in a research version of Monaco 
(Elekta)(figure 1). The second CT scan was used to mimic 
daily imaging at the MRL. The second CT was shifted in left-
right and superior-inferior direction from -5 to 5 cm and in 
the anterior-posterior direction from -1 to 1 cm. VCS plans 
were created for each shift resulting in 60 plans. These were 
further optimised by SWO (60 plans) and by both, SWO and 
SSO (60 plans).  
To determine the accuracy of all 180 plans, the dose 
distributions and DVH’s were evaluated and compared with 
the reference plan. Plans were acceptable if V107<2cm³, the 
V99 decreased less than 2%, the V95 decreased less than 1% 
and the Dmean differed maximal 1% from the reference plan. 
Also time was evaluated to determine the usability in an 
online situation at the MRL. 
 
 
 
Results: In total, 52% of the VCS plans were acceptable. Left-
right shifts resulted mainly in an unacceptable V107. 
Superior-inferior shifts resulted mainly in lower coverage. 
With SWO, 63% of the plans were accepted, the unaccepted 
plans had a V107>2cm³. With SWO+SSO, 98% of the plans 
were accepted. The last 2% failed due to minimal hotspots in 
the PTV. The average calculation time to create a reference 
plan was 205 sec. The mean calculation time of a VCS plan, 
SWO plan and SWO+SSO plan was 125 sec, 9 sec and 507 sec, 
respectively. 
 
Conclusion: VCS seems to work well for half of the cases, 
further optimization results in acceptable plans. The time to 
create VCS plans and SWO plans is compatible with an online 
setting. SWO+SSO results in stable plans. However, this takes 
long time in comparison with creating a new plan. To 
determine for what extent of shifts, acceptable plans can be 
created, more plans will be made. Then a trade of can be 
made when to create a VCS/SWO(+SSO) plan or start a new 
plan. 
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Purpose or Objective: During the 7 weeks of radiation 
therapy, the anatomy of head and neck cancer patients 
changes, resulting in a difference between planned and 
delivered dose. Currently, the allocation of adaptive 
radiotherapy (ART) is often based on visual inspection on 
repeated imaging or dosimetric criteria and thus only 
implicitly on changes in treatment outcome. Normal Tissue 
Complication Probability (NTCP) is a metric that translates 
the treatment dose distribution to treatment outcome. The 
goal of this study was to assess the impact of anatomical 
changes over the course of radiation therapy and the 
consequential difference in NTCP. 
 
Material and Methods: For 36 squamous cell head and neck 
cancer patients treated in a single tertiary cancer center, 
daily in room CT scans were made in treatment position using 
CT on rails. In post-treatment analysis, the original beam set 
up was used to calculate dose of the day. Additionally, the 
daily CT was deformably registered to the planning CT (pCT). 
These daily doses were propagated to the pCT and 
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accumulated to estimate the delivered dose after which the 
dose-volume histograms were calculated on the pCT using the 
original contours. Treatment plan adaptations applied in 
clinical practice were ignored in this analysis, assuming that 
ART does not affect anatomic changes. NTCP calculations 
were done based on the LKB model for both planned and 
delivered dose, using input parameters based on work by 
Burman et al. and Emami et al. (1,2) OAR were contoured if 
deemed at risk and subsequently peer-reviewed by a team of 
experienced head and neck radiation oncologists. The overall 
NTCP per patient was calculated by multiplication of the 
chance of no toxicity i.e.  
 
,for both the planned and delivered dose. 
 
Results: On average, 6 OAR per patient were contoured. In 8 
patients (22%), the difference in overall NTCP between 
planned and delivered dose was >3%. In half of them, NTCP of 
delivered dose was lower than planned. The largest 
difference in overall NTCP was 14% (Figure 1). The patients 
with the largest differences in overall NTCP could not be 
identified based on largest absolute dose differences for the 
OAR. Of the 8 patients that received ART clinically, 3 had an 
overall NTCP difference >3%.  
 
 
Conclusion: Differences >3% in overall NTCP between 
planned and delivered dose occur in about 1/4th of the head 
and neck cancer patients. Both increases and decreases in 
NTCP were observed, stressing the need for ART to either 
reduce NTCP or allow dose escalation. Expert opinion does 
not identify the same patients for ART as NTCP calculations 
do. A model to select patients for ART, however, should not 
only be based on changes in NTCP but should also include 
possible changes in TCP. Thus, further research is warranted 
to timely identify patients in which these differences occur, 
and on how to optimize the allocation of ART. 
1 C Burman et al, IJROBP, 1991  
2 B Emami et al, IJROBP, 1991 
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Purpose or Objective: Head and neck patients experience 
weight loss in a predictable pattern during treatment. CTV 
volumes typically reduce in volume by a third, as do the 
parotid glands. Adaptive methods for these patients focus on 
an offline protocol where the patient is rescanned and 
planned at two-to-three weeks through treatment, resulting 
in significant reduction in parotid doses. The MR linac 
(Elekta, AB, Stockholm, Sweden) will provide excellent soft 
tissue contrast which may be desirable for this group of 
patients, e.g., for tumour response monitoring. The presence 
of the magnetic field results in the Lorentz force causing 
electrons exiting the patient to spiral and be incident on the 
exit surface. This may potentially result in an increased dose 
to superficial tissues, i.e. the parotid glands. This effect can 
be controlled in plan optimisation. It is unknown, however, 
whether the presence of the magnetic field makes it 
necessary to adapt the plan at an earlier stage or more 
frequently during treatment. It is therefore the purpose of 
this paper to evaluate the effect of the magnetic field on 
need for adaptive radiotherapy in the head and neck. 
 
Material and Methods: Five patients were selected from the 
clinical archive that had shown significant weight loss during 
treatment and required a repeat CT. Both the initial planning 
CT and the repeat CT were fully contoured including spinal 
cord, brainstem, left and right parotids. An initial plan was 
created for the planning CT using Monaco, Elekta AB 
Stockholm, Sweden, which met the departmental constraints 
for OAR dose. This plan was optimised with the B field set to 
1.5T and then re-calculated at 0T, allowing the segmentation 
to remain constant. Plans were calculated with a 1% 
statistical uncertainty with the GPUMCD algorithm. The plans 
were transferred onto the re-scan CT and re-calculated. The 
magnitude of the change in dose to the OARs due to weight 
loss was compared between the 0T and 1.5T plans. 
 
Results: Table one shows the results of the analysis for the 
five initial patients investigated. Spinal cord, brainstem and 
parotid glands are included in the table. Entries in red show 
that the magnitude of change in the OAR dose is greater, 
resulting in a larger dose to that OAR compared to the 
complementary plan. The spinal cord and brainstem do not 
show a trend, with the 0T and 1.5T plans showing increase 
dose in an equal number of plans. However, for the parotid 
glands the magnitude of the change in dose is greater with 
the 1.5T field present with the majority of plans showing an 
increase. 
 
 
Conclusion: The results from these patients indicate that 
weight loss in head and neck patients results in a greater 
increase in dose to the parotid glands when treated in a 
magnetic field. Adaptive protocols for these patients 
therefore require more frequent adaption than the current 
mid-treatment approach.  
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Purpose or Objective: In SBRT for Locally Advanced 
Pancreatic Carcinoma (LAPC), the nearby organs of the GI 
tract are dose limiting. Given the daily positional variation of 
those OARs, the planning approach is conservative, often 
leading to concessions in the PTV coverage. The purpose of 
this study is to evaluate the daily variation in abdominal 
organ dose. 
 
Material and Methods: For this study, 5 patients were 
treated for LAPC with SBRT on a Cyberknife to a prescribed 
dose of 40 Gy in 5 fractions. During treatment, respiratory 
tracking was applied using implanted fiducials for real-time 
alignment of the treatment beams to the target. Planning 
constraints for the OARs included a maximum of 5 cc to 
